An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma.
PHASE2
This is a Phase 1/2 study evaluating the safety and anti-tumor activity of ...
A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers
PHASE1
A single 125 mg oral dose of the investigational compound PD-0332991 will b...
Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate
N/A
To provide access to palbociclib to post-menopausal women with HR-positive,...
Status
No Longer Available
Location
CBCC Global Research, Inc. at Comprehensive Blood & Cancer Center Research Center
To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
PHASE1
This is an open-label, multicenter, Phase I study designed to evaluate the ...
A Drug-Drug Interaction Study To Investigate The Potential For Multiple Doses Of Palbociclib (PD-0332991) To Alter The Pharmacokinetics Of Oral Midazolam In Adult Healthy Women of Non-Childbearing Potential.
PHASE1
This is a drug-drug interaction study to compare the pharmacokinetics of a ...